IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Supernus Pharmaceuticals Inc

CUSIP: 86845910 | 3 institutional holders

Quarters

Q3 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Arrowstreet Capital, Limited Partnership9,667
0.0% of portfolio›$239
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
9,667$2390.0%GARPHighBoston, MA2016-11-14